NEWS: New Accessory Enables QA BeamChecker Plus to Perform Seamless CyberKnife® QA
(Middleton, WI), February 13, 2018 -- Standard Imaging, Inc., a global leader in quality assurance for cancer treatment, announced that their QA BeamChecker PlusTM can now be used seamlessly for CyberKnife® QA when used with the new Cutting Board accessory.
“The Cutting Board provides a simple, elegant solution for CyberKnife users who want to take advantage of the fast and reliable results you get with the QA BeamChecker Plus,” said President Eric DeWerd, “We believe that this will save physicists and therapists both time and hassle.”
The QA BeamChecker Plus is a popular device for performing daily beam QA on linear accelerators, with over 1,200 units sold in the past ten years. The new Cutting Board accessory removes the need for manual manipulation of the robot, so alignment is quicker, easier, and more representative of the patient treatment workflow. It provides a streamlined, repeatable process than can be performed in a fraction of the time.
The Cutting Board contains embedded fiducial markers, making it possible to use the CyberKnife’s treatment localization system to align it with isocenter, instead of relying on manual adjustments by the user. The QA BeamChecker Plus unit is simply placed on top of the Cutting Board, along the clearly marked alignment groove. After alignment, the user is ready to perform their daily beam QA faster than ever before. Plus, with this simplified process, daily CyberKnife beam QA can be performed by therapists in a workflow that matches that of a standard linac, relieving some of the physicist’s workload.
The QA BeamChecker Plus and Cutting Board are part of Standard Imaging’s CyberKnife Solution.
Standard Imaging is a leading manufacturer of radiation calibration and quality assurance instruments for healthcare. The company was founded in 1989, and has become a leader in the medical physics field. Standard Imaging is committed to the fight against cancer by offering a suite of products aimed at supporting radiation therapy for cancer treatment.